Our Investigators
Contact |
Medical Speciality |
Interest Areas |
Experience |
|
A/Prof John Amerena Ph (03) 4215 1025
|
Cardiology |
|
More than 25 years' experience in cardiovascular studies. Both inpatient and outpatient cardiovascular outcome studies, including acute coronary syndrome, heart failure, diabetes, dyslipidaemia, atrial fibrillation and hypertension. |
|
Prof Eugene Athan Ph (03) 4215 2375
|
Infectious Diseases |
|
Over 15 years of active research and clinical trials experience as principal investigator on phase 1 b to phase 3 trials. |
|
Prof Michael Berk Ph (03) 4215 3320
|
Psychiatry |
|
Over 20 years of research experience in mental health. Esteemed clinician and academic. |
|
Dr Adam Broad Ph (03) 4215 2700
|
Medical Oncology |
|
Prior oncology clinical trials fellow (2004) during specialist training. Principal investigator in approximately 40 trials over 15 years via Barwon Health. Member of ALTG / IASLC / AGITG. |
|
David Campbell
|
Medical Oncology |
|
Clinical research experience over 10 years. Involved in phase 1,2 and 3 trials. Experience as principle investigator in trials including prostate, renal, bladder cancer, breast and gliomas. |
|
A/Prof Philip Campbell Ph (03) 4215 2751
|
Clinical Haematology and Stem Cell Transplantation |
|
More than 20 years' experience as a clinician researcher involved in investigator-initiated, cooperative group and sponsored phase I, 2 and 3 trials. |
|
A/Prof Olivia Dean Ph (03) 4215 3300
|
Psychiatric Clinical Trials Affective Disorders Research |
|
Over 15 years' research experience in mental health. 2019 Web of Science highly cited researcher. |
|
A/Prof Seetal Dodd Ph (03) 4215 3299
|
Psychopharmacology Pharmacokinetics Drug metabolism Drug safety |
|
Over 20 years' research experience in mental health, ranging from pre-clinical drug development to level 2 and 4 clinical trials. |
|
Rachel Fiddes Ph 0411 399 025
|
Anaesthesia and Pain |
|
Anaesthetics clinical trials. |
|
Dr Melissa Formica Ph 0411 399 025
|
Anaesthesia and Pain |
|
Focus of research being the effect of lifestyle factors on cognitive function in older adults. Extensive experience running research trials and has worked at Barwon Health for more than two years as a research fellow, coordinating multiple research trials. |
|
Dr Michael Francis Ph (03) 4215 2746 |
Radiation Oncology |
|
More than 18 years' involvement with TROG, ANZ Breast Cancer Trials Group, COGNO Trials Group. |
|
Dr Adam Friebe
|
Haematology |
|
Involvement in numerous clinical trials since clinical registrar (2011) - lymphoma, CML, thrombocytopenia, therapeutic anticoagulation, ITP. Potential involvement in upcoming aplastic anaemia. |
|
Dr David Fuller
|
Paediatrics |
|
Six years' experience as a principal investigator and co-investigator on paediatric clinical trials both commercially sponsor trials, including early phase trials in RSV, bacteremia and osteomyelitis. |
|
Dr Claire Furyk Ph (03) 4215 1901 |
Anaesthesia |
|
Principal investigator on small single centre studies published in 2018. Principal site investigator and associate site investigator on several ongoing multicentre trials in anaesthesia. |
|
Ian Grant
|
Palliative Care |
|
Trial investigator for trials related to pain, nausea, breathlessness, delirium, cachexia. |
|
Dr Andrew Hui Ph (03) 4215 2746
|
Radiation Oncology |
|
Nineteen years' experience as a radiation oncologist. Recruited patients into various trials over the years. |
|
Dr. Andrew Iliov
|
Anaesthesia and Perioperative Medicine |
|
|
|
Prof Felice Jacka |
Nutritional Psychiatry |
|
Dietary intervention - The SMILES trial (2012-2016) Moving Moods - FMT for major depressive disorder (2020-2023); Moo'D trial: A2 versus Conventional dairy for mood and cognition. |
|
Prof Mark Kotowicz Ph (03) 4215 2899
|
Endocrinology |
|
Over 45 years' experience in clinical investigation including studies concerning the pathogenesis, pathophysiology, epidemiology, diagnosis and treatment of osteoporosis, treatment of Paget’s disease of bone, treatment of Type 1 and Type 2 diabetes and their complications, including cardiovascular outcome studies, management of dyslipidaemia in diabetes and medical therapy of obesity. Principal investigator or co-investigator in over 80 industry and investigator-initiated phase 2-4 clinical trials. Over 200 publications in the peer-reviewed literature. |
|
Dr Anna Lomax |
Medical Oncology |
|
Trial fellow at Eastern Health 2013-2014. Phase 2-3. Melanoma/phase 1 fellow at Chris O'Brien Lifehouse. 2015-2016. Phase 1-3. Oncologist at University Hospital Geelong, melanoma, lung and GU clinical trials. Phase 2-3. |
|
Dr Matthew Maiden Head of ICU Research Contact: Allison Bone ICU Research Coordinator Ph 0403 603 545
|
Intensive Care |
|
An intensive care research department with experience in investigator initiated phase 2 and 3 clinical trials. |
|
Andrew Marriott
|
Anaesthesia, Perioperative Medicine and Pain |
|
Site principal investigator, local and national perioperative clinical trials. |
|
Peter Martin
|
Palliative Care |
|
Leading a dedicated Cachexia service for 15 years. Teaching healthcare communication for 25 years. |
|
Dr Maitham Mathlum Ph (03) 4215 5166
|
Radiation Oncology |
|
Senior radiation oncologist with 14 years’ experience oncological trials. Principle investigator for several international and local trials. Member of EORTC, TROG trial group. |
|
Dr Shannon McCarthy
|
Endocrinology |
|
Five years experience as sub-investigator and now principal investigator on international phase II-RCTs in diabetes, osteoporosis, Paget's disease, and obesity. |
|
Dr Kate McCloskey
|
Paediatrics |
|
More than 6 years' experience as an investigator on paediatric clinical trials, for both commercially sponsor and investigator initiated trials, including early phase trials in RSV, bacteremia and osteomyelitis. |
|
Dr Inger Olesen
|
Oncologist |
|
Over 10 years' experience as a PI and SubI in trials (phase 1-3). |
|
Prof Richard Page Contact: Sally Beattie Orthopaedic Research Manager Ph (03) 4215 2208
|
Orthopaedics Musculoskeletal Sciences |
|
Thromboprophylaxis trials phase 2b and 3 (2001–ongoing). Multicentre and international trauma outcome trials (2003-ongoing). Shoulder, hip and knee replacement outcomes - RCTs – phase 3+ (2009-ongoing). Antibiotic usage in orthopaedic infection RCT. Analgesia in orthopaedic surgery RCTs (phase 2 and 3). |
|
Dr Mark Perrin |
Cardiologist and Electrophysiologist |
|
Post-doctoral research in Ottawa, Canada. Clinical fellowship Ottawa, Canada for two years, six years in Geelong. |
|
Dr Sumi Ratnasingam
|
Haematology |
|
Malignant haematology clinical trials fellow at Monash Haematology for two years. Sub-investigator for 40+ trials and in charge of managing many of these malignant trials ranging from phase 1b to phase 3 trials. Clinical haematologist and investigator for trials at Andrew Love Cancer Centre (ALCC). PI for B-MIND (phase III), HARBOUR (Phase 1b-II) and HMPL-523 (phase 1-II) clinical trials. SI for all other remaining trials. Honorary haematologist and sub-investigator for aggressive lymphoma trials including CAR T studies at Peter MacCallum Cancer Centre (2019-current). |
|
Hannah Rose |
Haematology |
|
Over six years' experience as an investigator on over 20 clinical trials, including as principal investigator on large international phase 3 trials in Hodgkins and Non-Hodgkins lymphoma. Results from these trials have been presented at international conferences and in peer reviewed journals. |
|
Dr Cameron Shaw Ph (03) 42150710
|
Neurology |
|
Local principal investigator for several multicentre RCTs and observational studies of disease-modifying therapies in Multiple Sclerosis. Collaborator in large scale epidemiological studies (e.g. AUSImmune, MSBase). |
|
Madhu S Singh
|
Medical Oncology |
|
Thirteen years' experience. Interest in Phase 1. 2 ,3 trials. |
|
Dr Shu Fen Wong
|
Medical Oncology |
|
Five clinical years as a specialist; experience with phase 1 trials as a trials fellow at Royal Melbourne Hospital in 2012; now have experience with phase 2 and 3 trials at University Hospital Geelong. |
|
A/Prof Daniel O’Brien Ph (03) 4215 2375
|
Infectious Diseases |
|
Clinical research |
Last Modified: Monday, 06 July 2020